Intravitreal Bevacizumab Injection Therapy in a Case with Choroidal Neovascular Membrane Secondary to Toxoplasmosis Retinochoroiditis

A 57-year-old male patient presenting with visual loss in the left eye was diagnosed as choroidal neovascular membrane secondary to inactive toxoplasmosis retinochoroiditis scar. He underwent intravitreal bevacizumab injection as primary therapy. The choroidal neovascular membrane regressed partia...

Full description

Bibliographic Details
Published in:	Türk Oftalmoloji Dergisi
Main Authors:	Sirel Gür Güngör, İmren Akkoyun, Evin Şingar, Gürsel Yılmaz
Format:	Article
Language:	English
Published:	Turkish Ophthalmology Society 2014-05-01
Subjects:	Choroidal neovascular membrane toxoplasmosis retinochoroiditis bevacizumab
Online Access:	http://www.oftalmoloji.org/article_6099/Intravitreal-Bevacizumab-Injection-Therapy-In-A-Case-With-Choroidal-Neovascular-Membrane-Secondary-To-Toxoplasmosis-Retinochoroiditis

Similar Items

Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis
by: Rishi Pukhraj, et al.
Published: (2011-01-01)

Transient mydriasis in toxoplasmosis retinochoroiditis
by: Bilal Rana, et al.
Published: (2020-06-01)

Idiopathic choroidal neovascular membrane in a young female
by: Saad Abdullah Waheeb, et al.
Published: (2009-01-01)

Focal Choroidal Excavation in a Case of Choroidal Osteoma Associated with Choroidal Neovascularization
by: Mahdieh Azimizadeh, et al.
Published: (2020-08-01)

Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
by: Farhad Fazel Najafabadi, et al.
Published: (2015-01-01)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
by: Elad Moisseiev, et al.
Published: (2010-08-01)

Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor
by: Rupak Roy, et al.
Published: (2017-01-01)

Combination of photodynamic therapy with intravitreal bevacizumab for post-peribulbar anesthesia (penetrating trauma)-persistent choroidal neovascular membrane
by: Shah Nikunj, et al.
Published: (2008-01-01)

Intravitreal bevacizumab for neovascular age-related macular degeneration
by: Junn R. Pajarillo, MD, et al.
Published: (2009-12-01)

Intravitreal bevacizumab for choroidal neovascular membrane associated with Best′s vitelliform dystrophy
by: Rishi Ekta, et al.
Published: (2010-01-01)

Unilateral congenital ocular toxoplasmosis
by: Aymane Ridallah, et al.
Published: (2020-06-01)

Anti-vascular endothelial growth factors for choroidal neovascularization secondary to choroidal osteoma: Long-term results
by: T Lekha, et al.
Published: (2015-01-01)

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors
by: Fabiana Mallone, et al.
Published: (2021-10-01)

Retinal ferroptosis as a critical mechanism for the induction of retinochoroiditis during ocular toxoplasmosis
by: Kazuhisa Yamada, et al.
Published: (2023-11-01)

Trabeculectomy with concurrent intravitreal bevacizumab in neovascular glaucoma
by: Sardar M Khan, et al.
Published: (2024-01-01)

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization
by: Rui Gao, et al.
Published: (2021-01-01)

Treatment of ocular toxoplasmosis in pregnancy
by: Leila I. Kump, MD, et al.
Published: (2004-06-01)

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
by: Almila Sarıgül Sezenöz, et al.
Published: (2017-08-01)

Factors of occurrence of ocular toxoplasmosis. A review*
by: Talabani H., et al.
Published: (2010-09-01)

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Endogenous Endophthalmitis
by: Shwu-Jiuan Sheu
Published: (2009-11-01)

Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
by: Stephanie Rico, et al.
Published: (2024-06-01)

Severe ocular sequelae of congenital toxoplasmosis: huge macular scar
by: Fadoua Zahir, et al.
Published: (2015-03-01)

Neuroretinitis and Juxtapapillary Retinochoroiditis as Atypical Presentations of Ocular Toxoplasmosis
by: Kabedi NN, et al.
Published: (2021-09-01)

Choroidal extranodal marginal zone lymphoma diagnosed by full-thickness retinochoroidal biopsy: case report and review of the literature
by: Dirani A, et al.
Published: (2017-05-01)

Clinical Profile and Outcomes of Patients with Toxoplasmic Retinochoroiditis: A Tertiary Care Center Experience
by: Alshalan HA, et al.
Published: (2025-10-01)

Choroidal Osteoma with Choroidal Neovascularization and Focal Choroidal Excavation
by: Rajwinder Kaur, et al.
Published: (2021-10-01)

Indocyanine Green Mediated Photothrombosis (IMP) with Intravitreal Bevacizumab (IVB) for Treatment of Choroidal Neovascular Membrane (CNV) due to ARMD
by: Anisha Seth, et al.
Published: (2016-04-01)

Atypical acquired toxoplasmosis
by: Shakha, et al.
Published: (2024-05-01)

Treatment of juxtapapillary toxoplasmic retinochoroiditiswith intravitreal clindamycin and dexamethasone injection
by: Edmin Michael G. Santos, MD
Published: (2008-12-01)

Ocular toxoplasmosis: the influence of patient age
by: Gary N Holland
Published: (2009-03-01)

Recurrent and De Novo Toxoplasmosis Retinochoroiditis following Coronavirus Disease 2019 Infection or Vaccination
by: Mélanie Hébert, et al.
Published: (2022-10-01)

Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
by: Zhe-Li Liu, et al.
Published: (2013-04-01)

A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma
by: Takako Hidaka, et al.
Published: (2018-08-01)

Intravitreal topotecan inhibits laser-induced choroidal neovascularization in a rat model
by: Mohammad Ali Gholipour, et al.
Published: (2015-01-01)

Atypical pattern of ocular toxoplasmosis: recurrent inner foveal toxoplasmic retinitis (rifter)
by: Guilherme Macedo Souza, et al.
Published: (2023-11-01)

Intravitreal bevacizumab for iatrogenic choroidal neovascular membrane following vitreoretinal surgery for retinal detachment
by: Ramya Appanraj, et al.
Published: (2020-01-01)

Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01)

Morphological and functional retinal changes in neovascular age-related macular degeneration treated with intravitreal bevacizumab
by: Deepali R Damkondwar, et al.
Published: (2022-01-01)

Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
by: Aditi Gupta, et al.
Published: (2014-01-01)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021-06-01)